EP2206728

REGENTS OF THE UNIVERSITY OF MINNESOTA
Application Number
EP10151672A
Filing Date
Apr 7, 2005
Status
Revoked
Nov 4, 2022
Grant Date
Oct 10, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2206728B9 was granted on Oct 10, 2018 by Regents OF The University OF Minnesota The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSDec 14, 2018ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS2004237124
N/A
OppositionWO0164247
N/A
OppositionWO02096458
N/A
OppositionUS5147294
N/A
OppositionWO2004096122
N/A
OppositionUS6548062
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.